Angola vs Somalia: Death rate from cancer
Angola
45.17 deaths per 100,000 people
in 2021
Somalia
45.29 deaths per 100,000 people
in 2021
Angola rank
167th
Somalia rank
166th
Death rate from cancer over time
- Angola
- Somalia
How they compare
Somalia currently reports 45.29 deaths per 100,000 people against 45.17 deaths per 100,000 people in Angola, a difference of 0.12 deaths per 100,000 people.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Somalia ahead.
Angola ranks 167th and Somalia ranks 166th of 194 countries.
Across the 3 decades both report, Angola averaged higher in 1 and Somalia in 2.
Head to head by decade
| Decade | Angola | Somalia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.82 deaths per 100,000 people | 58.19 deaths per 100,000 people | 4.37 deaths per 100,000 people | Somalia |
| 2010s | 53.66 deaths per 100,000 people | 55.68 deaths per 100,000 people | 2.02 deaths per 100,000 people | Somalia |
| 2020s | 47.42 deaths per 100,000 people | 46.28 deaths per 100,000 people | 1.14 deaths per 100,000 people | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer, Angola or Somalia?
- Somalia, at 45.29 deaths per 100,000 people against 45.17 deaths per 100,000 people in Angola as of 2021.
- What is the difference in death rate from cancer between Angola and Somalia?
- 0.12 deaths per 100,000 people, with Somalia ahead.
- How many years of comparable data are there for Angola and Somalia?
- 22 years are reported by both, from 2000 to 2021.
- How do Angola and Somalia rank globally for death rate from cancer?
- Angola ranks 167th and Somalia ranks 166th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes, per 100,000 people.